U.S. Markets open in 5 hrs 52 mins

Investors Who Bought Edwards Lifesciences (NYSE:EW) Shares Five Years Ago Are Now Up 314%

Simply Wall St

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly amazing gains over the years. To wit, the Edwards Lifesciences Corporation (NYSE:EW) share price has soared 314% over five years. And this is just one example of the epic gains achieved by some long term investors.

View our latest analysis for Edwards Lifesciences

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

Over half a decade, Edwards Lifesciences managed to grow its earnings per share at 21% a year. This EPS growth is lower than the 33% average annual increase in the share price. This suggests that market participants hold the company in higher regard, these days. And that's hardly shocking given the track record of growth. This favorable sentiment is reflected in its (fairly optimistic) P/E ratio of 48.46.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

NYSE:EW Past and Future Earnings, May 10th 2019

We know that Edwards Lifesciences has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.

A Different Perspective

We're pleased to report that Edwards Lifesciences shareholders have received a total shareholder return of 30% over one year. Having said that, the five-year TSR of 33% a year, is even better. If you would like to research Edwards Lifesciences in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.

Of course Edwards Lifesciences may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.